How Long Does Semaglutide Take to Work?

Semaglutide is a marathon. Not because the medication takes a long time to start affecting your body, but because the weight loss itself unfolds over many months. Understanding the actual timeline prevents the two most common failure modes: quitting at week 3 because results seem slow, or giving up at month 4 because you expected to be done by now. This post covers the real timeline of semaglutide, week by week and phase by phase.

How Long Does Semaglutide Take to Work on Appetite

The appetite suppression effect of semaglutide starts quickly. Most patients report reduced hunger within the first 3 to 7 days of the starting dose (0.25 mg weekly). This is because semaglutide begins binding to GLP-1 receptors in the brain as soon as it reaches therapeutic blood levels, which happens within the first week.

Early appetite changes are typically subtle:

• Feeling full sooner during meals
• Forgetting to eat snacks you would normally want
• Food noise (background thoughts about eating) quiets down
• Sweet or high-fat cravings feel less urgent

These effects strengthen with each dose increase. The 0.25 mg starting dose produces noticeable but modest appetite changes. By 1.0 mg (month 3), most patients describe a substantial change in how they relate to food. By 2.4 mg (month 5 onward), appetite suppression is often dramatic.

The disconnect that catches patients off guard: appetite changes happen fast but weight loss lags. You can be eating half of what you used to eat by week 2 but see minimal scale movement for another 2 to 4 weeks because of water weight fluctuations and your body’s adjustment period.

Week-by-Week Timeline on Semaglutide

This is what the typical journey looks like. Individual variation is real, but this template fits most patients reasonably well.

Week 1 (starting dose 0.25 mg)

First injection given. Blood levels climb. By day 3 most patients notice some appetite reduction. Nausea is most common in the first 72 hours after the first injection. Scale may shift slightly due to water changes.

Weeks 2-4 (continuing 0.25 mg)

Appetite changes solidify. Scale often shows 1 to 4 pounds loss cumulatively. Side effects either settle down (majority) or require management strategies (minority). Some patients wonder if the medication is working because the pace feels slow. This is normal.

Week 5 (dose increase to 0.5 mg)

The dose roughly doubles. Some patients get a wave of fresh nausea for 3 to 7 days after the first injection at the new dose. Appetite suppression intensifies.

Weeks 6-8 (continuing 0.5 mg)

Weight loss accelerates for most patients. Typical pace: 1 to 2 pounds per week. Cumulative loss at week 8 often 6 to 12 pounds. This is the phase where the medication visibly starts working.

Week 9 (dose increase to 1.0 mg)

Another potential nausea wave. Continued appetite reduction.

Weeks 10-12 (continuing 1.0 mg)

Steady pace of 1.5 to 2.5 pounds per week for most patients. Cumulative loss at 3 months typically 15 to 25 pounds for a 220-pound starting weight.

Week 13 (dose increase to 1.7 mg)

Nausea potential again. Appetite suppression deepens.

Weeks 14-20 (continuing 1.7 mg)

Pace usually holds or slows slightly. Cumulative loss at 5 months often 25 to 45 pounds for a 220-pound start. Many patients could technically maintain on this dose if side effects are prohibitive at 2.4 mg.

Week 21 (dose increase to 2.4 mg – maintenance dose)

Final escalation. Some patients have significant nausea; others tolerate this jump well. Peak appetite suppression.

Months 6-15 (maintenance dose 2.4 mg)

The long arc of weight loss. Most of the total weight loss happens during this phase. Pace slows from the early acceleration to a steadier decline of 3 to 6 pounds per month. Cumulative loss by month 12 typically 30 to 50 pounds (14 to 23 percent of starting weight) for an average responder.

Months 15-18

Plateau phase begins for most patients. Weight stabilizes at a new set point. This is normal and not a treatment failure. Future weight loss would require additional interventions (diet escalation, medication change, or dose increase).

Why Does Semaglutide Take So Long to Reach Full Effect

The graduated titration exists for a reason. Clinical research demonstrated that starting patients at the full 2.4 mg dose caused severe GI side effects in most people, leading to high dropout rates. The slow escalation dramatically improves tolerability at the cost of a delayed therapeutic peak.

The FDA-approved prescribing information for Wegovy mandates the 16-week titration period specifically for this safety reason. Many clinicians extend it further when side effects are significant, going to 20 or even 24 weeks before maintenance dose if needed.

Trade-off to understand: you cannot rush semaglutide to peak effect without paying a steep price in side effects and dropout risk. The patients who try to push faster almost always regret it.

The Patients Who See Fast Results

A minority of patients see significant scale movement in the first 3 weeks. Common factors:

• Very responsive to GLP-1 agonists biologically (not predictable in advance)
• Previous fluid retention that drops off quickly
• Aggressive lifestyle changes started simultaneously
• Lower baseline body weight (numbers move faster)

If you are one of these fast responders, fantastic. If you are not, do not let social media success stories or a friend’s faster loss shake your commitment. The distribution of response speed is wide, and slow starters often become strong finishers.

The Patients Who Feel Like It’s Not Working

At week 4 or 5, some patients conclude that semaglutide is not working for them. The scale has barely moved. Appetite reduction is there but not dramatic. They are considering quitting.

Patients with minimal week 4 response often catch up by month 3 and hit normal response ranges by month 6.

Quitting at week 4 is almost always premature. At minimum, completing the full 16-week titration to maintenance dose is needed to know if semaglutide is working for you.

Signs it genuinely is not working (after month 6):

• Less than 5 percent body weight loss at the full dose
• No appetite suppression effect despite adequate dosing
• No improvement in food cravings

These patients may benefit from switching to tirzepatide or investigating other metabolic factors. See our troubleshooting guide for the full decision tree.

Timeline Variation by Gender and Age

Men and women respond similarly to semaglutide in trials, but real-world patterns show subtle differences:

Men often see slightly faster initial weight loss due to higher starting metabolic rate and typically more muscle mass. Absolute pound loss tends to be larger.

Women sometimes have more variable early response due to menstrual cycle effects on water retention. Premenopausal women should judge progress over 4-week rolling averages rather than week-to-week.

Postmenopausal women may see blunted response due to declining estrogen affecting metabolic rate. The effect is real but usually modest. See our cross-discussion in menopause and weight gain.

Older patients (60+) often lose weight slightly slower in absolute terms but not in percentage. The timeline template still applies.

Side Effects Timeline

Side effects follow their own predictable pattern, separate from weight loss:

Weeks 1-2: Nausea at peak for most patients. Some experience vomiting. Fatigue common.

Weeks 3-4: Side effects settling down as body adjusts. Most patients feel relatively normal at the starting dose.

Dose increase weeks (5, 9, 13, 21): Potential resurgence of nausea for 3 to 7 days. Intensity usually lower than first-dose nausea.

Between dose increases: Relative stability. GI symptoms typically mild.

Long-term (months 6+): Constipation can emerge as a later-developing issue even in patients who had no GI problems early on. Hydration and fiber matter more over time.

A STEP 1 trial published in the New England Journal of Medicine documented that GI side effects peaked in the first 20 weeks, with most events mild to moderate and transient. Severe events requiring discontinuation occurred in about 4 percent of treated patients.

What to Watch For at Each Phase

To optimize your semaglutide timeline:

Weeks 1-4: Focus on side effect management and building routines. Scale movement is not the metric yet. Eating 75 to 80 percent of your prior volume is a good target.

Weeks 5-16: Start tracking weight weekly. Focus on protein intake (0.7-1.0 g/lb body weight). Begin or continue resistance training 2 to 3 times per week.

Weeks 17-24: Maintenance dose. Refine lifestyle patterns. Build habits that will outlast the medication.

Months 6-12: Monitor for plateau signs. Most of the weight loss happens here. Clinical check-ins every 2 to 3 months.

Months 12-18: Plateau expected. Discuss maintenance strategy with your provider. This is when decisions about continuation, transition, or careful discontinuation get made.

The Bottom Line on Semaglutide Timeline

Semaglutide starts working on your appetite within a week. It takes 4 to 8 weeks to show clearly on the scale. The full therapeutic dose arrives at month 5. Peak weight loss unfolds from months 6 through 15. Plateau typically follows. Patience through the titration phase is the single most important factor in getting good results from this medication.

Medically Reviewed By

Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC

Medical Director at Tactus Health. Dual board-certified nurse practitioner specializing in medical weight loss, hormone therapy, and metabolic health. Sugar Hill, GA with telehealth for Georgia patients.